All Episodes
ASCO Education — 201 episodes
Modern Management of Mantle Cell Lymphoma: Biological Risk, BTKi, and Beyond
Optimizing Frontline ADCs: Sequencing, Targets, and Resistance
Expanding Precision Oncology With Targeted Immunotherapy
Beyond Chronological Age: Assessing Frailty in Older Adults With GU Cancer
Liver-Directed Therapies for Colorectal Cancer: Where Are We Now?
Exercise as Medicine: Strategies for Integrating Exercise into Cancer Care
Is Organ Preservation for GEJ and Gastric Cancers Ready for Primetime?
Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras
Making Clinical Trial Participation a Standard of Care in Oncology
Key Updates in Testicular Cancer: Optimizing Survivorship and Survival
The Evolving Landscape of Bispecific Antibodies in Hematologic and Solid Tumors
Emerging Treatment Paradigms in Genitourinary Cancers
Interventions to Reduce Financial Toxicity in Breast Cancer
Oncology and Suffering: Strategies on Coping with Grief for Health Care Professionals
Addressing Barriers and Leveraging New Technologies in Lung Cancer Screening
Incorporating Integrative Oncology Into Practice for GI Cancers and Beyond
The Evolution of the ASCO Educational Book and the Issues Shaping the Future of Oncology
Cancer Topics - Oncology Practice in Low-Resource Settings
Cancer Topics - Oncology Practice In Rural Settings Part 2
Oncology, Etc. – Dr. Patricia Ganz' Evolutionary Treatment Of The Whole Patient
Cancer Topics – ICC Program Malaysia
Oncology, Etc. – The Diversity Mission with Dr Edith Mitchell
Cancer Topics – Research to Practice: Prostate Cancer (Part 2)
Oncology, Etc. – Dr. Lori Pierce's Path From Engineering To Oncology
Cancer Topics - Oncology Practice In Rural Settings Part 1
Oncology, Etc. – Pioneering Geriatric Cancer Care with Dr. Hyman Muss
Cancer Topics – Alternative to 10-Year ABIM MOC Exam: Longitudinal Knowledge Assessment
Cancer Topics – Research to Practice: Prostate Cancer (Part 1)
Oncology, Etc. – Devising Medical Standards and Training Master Clinicians with Dr. John Glick
Cancer Topics - How To Keep Up With Advances In Oncology
Oncology, Etc: - Cancer Care Partnership With Kenya
Cancer Topics - Racial Disparities in Clinical Trial Participation
Oncology, Etc. - Passion For Writing And Medicine With Dr. Lisa Rosenbaum
Advanced Practice Providers - APPs in Oncology
Oncology Etc: Dr. Miriam Mutebi on Improving Cancer Care in Africa
Oncology Etc – Global Cancer Policy Leader Dr. Richard Sullivan Part 2
Cancer Topics - My Approach to Refractory Diffuse Large B-Cell Lymphoma
Oncology, Etc. – Global Cancer Policy Leader Dr. Richard Sullivan (Part 1)
Cancer Topics – Oncology Training – Past, Present, Future Part 2
Cancer Topics – Oncology Training – Past, Present, Future Part 1
Oncology, Etc. – HPV Vaccine Pioneer Dr. Douglas Lowy (Part 2)
Oncology, Etc. – HPV Vaccine Pioneer Dr. Douglas Lowy (Part 1)
Oncology, Etc. – In Conversation with Dr. David Steensma (Part 2)
Cancer Topics - Impact of Implicit Racial Bias on Oncology Patient Care and Outcomes
Oncology, Etc. - In Conversation with Dr. David Steensma (Part 1)
Advanced Practice Providers - An APP's Scope of Practice
Cancer Topics - Increasing Diversity in Oncology Practices (Part 2)
Oncology, Etc. - In Conversation with Dr. Peter Bach (Part 2)
Cancer Topics - Increasing Diversity in Oncology Practices (Part 1)
Oncology, Etc. - In Conversation with Dr. Peter Bach (Part 1)
Advanced Practice Providers – APPs 101: Physician Assistants (PAs) and Advanced Practice Registered Nurses (APRNS) in Oncology
Oncology, Etc. - Finding Your Voice: A Tale of Healing and Rediscovery
Cancer Topics - Career Paths in Oncology (Part 2)
Oncology, Etc. – In Conversation with Dr. Richard Pazdur (Part 2)
Cancer Topics - Career Paths in Oncology (Part 1)
Advanced Practice Providers - APPs 101: What and Who Are Advanced Practice Providers (APPs)?
Oncology, Etc. – In Conversation with Dr. Richard Pazdur (Part 1)
Cancer Topics – Financial Toxicity
Oncology, Etc. – Rediscovering the Joy in Medicine with Dr. Deborah Schrag (Part 2)
Oncology, Etc. – Rediscovering the Joy in Medicine with Dr. Deborah Schrag (Part 1)
Oncology, Etc. – Mr. Paul Goldberg: Interviewing the Interviewer (Part 2)
Cancer Topics – Medical Aid in Dying
Oncology, Etc. – Mr. Paul Goldberg: Interviewing the Interviewer (Part 1)
Oncology, Etc. — Out of this World: Astronaut Physicians (Part 2)
Cancer Topics – Delivering Serious News (Part 2)
Oncology, Etc. - Out of this World: Astronaut Physicians (Part 1)
Cancer Topics – Delivering Serious News (Part 1)
Oncology, Etc. - Female Leadership in Practice: Two ASCO Leadership Development Program Success Stories
Cancer Topics – Medicinal Cannabis
Oncology, Etc. - In Conversation with Dr. Quyen Chu
Cancer Topics – Beyond Adjuvant Chemotherapy: Precision Oncology in Early-stage NSCLC
Oncology, Etc. - From Personal to Politics – A Discussion about COVID and Oncology
Oncology, Etc. - On Leadership and Pearls of Life with Dr. Susan Desmond-Hellmann (Part 2)
Cancer Topics - New Therapies for Lymphoma (Part 2)
Oncology, Etc. – On Leadership and Pearls of Life with Dr. Susan Desmond-Hellmann (Part 1)
Cancer Topics - New Therapies for Lymphoma (Part 1)
Oncology, Etc. - In Conversation with Dr. Otis Brawley (Part 2)
Oncology, Etc. - Introducing Oncology, Etc.: Friendship, and the Majesty of our Profession
Cancer Topics - Young-onset Colorectal Cancer
Cancer Topics - Burnout in Oncology: Trainee Perspective
Cancer Topics - Burned Out? Here's What You Can Do About It (Part 2)
Cancer Topics - Burned Out? Here's What You Can Do About It (Part 1)
Cancer Topics - COVID-19's Impact on Oncology Trainees
Cancer Topics - Can You Hear Me Now? Challenges and Benefits of Telemedicine
Cancer Topics - Role of PARP Inhibitors in Prostate Cancer
Cancer Topics - Immunotherapy Breakthroughs in Esophageal Cancers
Cancer Topics - Adjusting Cancer Care During Covid-19
Cancer Topics - Exercise Can Benefit Our Cancer Patients
Cancer Topics - CAR T-cells in Pediatric ALL
Cancer Topics - Contrasting Cases: EGFR Mutant NSCLC
Cancer Topics - Contrasting Cases: Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade
Cancer Topics - Contrasting Cases: Cultural Barriers to Care
Cancer Topics - Contrasting Cases: Systemic Therapy for Metastatic Triple-negative Breast Cancer
Cancer Topics - Recent Approvals: Erdafitinib and Enfortumab for Second-Line Treatment of Metastatic Bladder Cancer
Cancer Topics - ASCO Guidelines: Molecular Biomarkers in Localized Prostate Cancer Guideline
Cancer Topics - ASCO Guidelines: Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards
Cancer Topics - ASCO Guidelines: Disease Management for Patients With Advanced HER2 Positive Breast Cancer and Brain Metastases Guideline
Cancer Topics - ASCO Guidelines: Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Guideline
Cancer Topics - ASCO Guidelines: Antimicrobial Prophylaxis for Adult Patients with Cancer-Related Immunosuppression Guideline
Cancer Topics - ASCO Guidelines: Treatment of Patients with Early-Stage Colorectal Cancer Resource-Stratified Guideline
Cancer Topics - ASCO Guidelines: Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer Update
Cancer Topics - ASCO Voices 2019: I Promised
Cancer Topics - ASCO Guidelines: Medication-Related Osteonecrosis of the Jaw Guideline
Cancer Topics - ASCO Voices 2019: Whose Breast Is It Anyway? Breast Cancer and Sexuality in Sub-Saharan Africa
Cancer Topics - ASCO Guidelines: Management of Osteoporosis in Survivors of Adult Cancers with Nonmetastatic Disease Guideline
Cancer Topics - ASCO Guidelines: Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer Guideline Update
Cancer Topics - ASCO Voices 2019: The Obligation of the Cured
Cancer Topics - ASCO Guidelines: Use of Endocrine Therapy for Breast Cancer Risk Reduction Guideline
Cancer Topics - Recent Approvals: Trastuzumab and Hyaluronidase-oysk
ASCO Voices 2019: Surgery Is Never Elegant When Women Are in the Operating Room
ASCO Guidelines: Use of Biomarkers to Guide Decisions on Adjuvant Therapy for Early-Stage Invasive Breast Cancer Guideline Update
ASCO Guidelines: HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma
ASCO Guidelines: Radiation Therapy for Glioblastoma
ASCO Guidelines: Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer PCO
ASCO Guidelines: Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer Guideline
ASCO Guidelines: Management of Cancer-associated Anemia with Erythropoiesis-Stimulating Agents Guideline
Annual Meeting 2019 - EGFR Inhibitors
Annual Meeting 2019 - Hepatocellular Carcinoma
Annual Meeting 2019 - PD1 Inhibitor Resistance in PDL1 Overexpressed Tumor
Annual Meeting 2019 - Managing Burnout in Oncology
Annual Meeting 2019 - Beyond Anti-PD-1/PD-L1 Therapy in Urothelial Cancer
Annual Meeting 2019 - Clinical Conundrums in the Management of Rectal Cancer
Annual Meeting 2019 - Integrating Biomarkers and Targeted Therapy into Colorectal Cancer Management
Annual Meeting 2019 - The Role of Adjuvant Radiotherapy in Management of Nodal Disease
Annual Meeting 2019 - Disparities in Prostate Care
Annual Meeting 2019 - The Stage IV Melanoma: What Biomarkers and Treatments Are Appropriate in the Frontline Setting?
Annual Meeting 2019 - Sustainable Oncology Research Programs
Annual Meeting 2019 - Contrasting Cases: Molecular Profiling in Breast Cancer
Immunotherapy and Changes in Standard Practice in Local Regionally Advanced Non-Small Cell Lung Cancer
Self-Evaluation: Central Nervous System
Self-Evaluation: Head & Neck Cancer
ASCO Guidelines: Safe Handling of Hazardous Drugs
Contrasting Cases: Frontline Immunotherapy in Metastatic Non-Small Cell Lung Cancer
Contrasting Cases: Cancer Prevention
ASCO Guidelines: Treatment of Multiple Myeloma
ASCO Guidelines: Anticonvulsant Prophylaxis and Steroid Use in Adults with Metastatic Brain Tumors Endorsement
ASCO Guidelines: Adjuvant Therapy for Resected Biliary Tract Cancer
Self-Evaluation: Chemotherapy Dosing for Patients with Morbid Obesity
Contrasting Cases: TAILORx- Chemotherapy or no?
Self-Evaluation: Soft-Tissue Sarcomas-Epidemiology
ASCO Guidelines: Adjuvant Endocrine Therapy for Women with Hormone Receptor Positive Breast Cancer Guideline
Contrasting Cases: Nephrectomy
Recent Approvals: Larotrectinib for the Treatment of Advanced Solid Tumors Containing NTRK Gene Fusion
Recent Approvals: Duvelisib for Adult Patients with Relapsed or Refractory CLL or SLL
ASCO Guidelines: Evaluating Susceptibility to Pancreatic Cancer PCO
ASCO Guidelines: Hypofractionated Radiation Therapy for Localized Prostate Cancer Guideline
Recent Approvals: Cemiplimab Approval for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma
ASCO Guidelines: Initial Diagnostic Workup of Acute Leukemia Guideline
New Drugs: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with Susceptible IDH1 Mutation
Self-Assessment: Predictive and Prognostic Rule of Pathological Complete Response in Breast Cancer Treatment
Recent Drug Approvals: Lenvatinib Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Self-Evaluation: Multiple Myeloma and Plasma Cell Dyscrasias- MGUS
Self-Evaluation: Lung Cancer Screening
ASCO Guideline: HER2 Testing in Breast Cancer
Self-Evaluation: Non-Small Cell Lung Cancer (NSCLC) - Locally Advanced
ASCO Guideline: Metastatic Pancreatic Cancer
Self-Evaluation: Treatment of Multiple Myeloma Plasma Cell Leukemia
Annual Meeting 2018 - ASCO Voices: Did You Ever Know That You're My Hero
Self-Evaluation: Gastric Cancer Diagnosis
ASCO Guideline: Practical Assessment and Management of Vulnerabilities
Self-Evaluation: Small Cell Lung Cancer
Recently Approved Drugs: Nivolumab for patients with metastatic small cell lung cancer
ASCO Guideline: Palliative Care in the Global Setting
Annual Meeting 2018 - ASCO Voices: Heroes, Mentors, and Hope
Self-Evaluation: Breast - Partial Mastectomy Follow-Up
Special Episode: Non-Hodgkin Lymphoma
Annual Meeting 2018 - ASCO Voices: The Call
Recently Approved Drugs: Lutetium Lu 177 dotatate for treatment of GEP-NETs
ASCO Guideline: Antiemetics Guideline for Treatment-Induced Nausea and Vomiting
Self-Evaluation: Breast
Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)
Self-Evaluation: Special histologies - lymphoma: Primary CNS, appropriate first line therapy for newly diagnosed primary CNS lymphoma
ASCO Guideline: Fertility Preservation in Patients with Cancer
Self-Evaluation: EGFR Mutation
Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer
ASCO Guidelines: Outpatient Management of Fever and Neutropenia
Self-Evaluation: NSCLC Treatment Metastatic
Adjuvant Treatment in Melanoma: Recent Advances
Recently Approved Drugs: Blinatumomab for B-cell precursor ALL
Guidelines: Management of Immune-Related Adverse Events
Treatment Effects & Transition to Survivorship for AYA Patients
EHR Chemotherapy Error: Breast Cancer
Continuity of Care for AYAs
Self-Evaluation: Clinical Trials Informed Consent Process
Self-Evaluation: Clinical Trials
Self-Evaluation: NSCLC
Self-Evaluation: Breast Cancer
Self-Evaluation: Metastatic Breast Cancer
ASCO Guidelines: Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer Update
Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer
Self-Assessment: Metastatic Prostate Cancer
Recently Approved Drugs: Pembrolizumab for cHL
ASCO Guidelines: Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
ASCO Guidelines: Management of Small Renal Masses
ASCO Guidelines: Potentially Curable Pancreatic Cancer
ASCO Guidelines: Secondary Prevention of Cervical Cancer
ASCO Guidelines: Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers
ASCO Guidelines: Pancreatic Cancer
ASCO Guidelines: Palliative Care
ASCO Guidelines: Pancreatic Cancer
ASCO University Weekly Podcast Series